دیدانوزین (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "دیدانوزین" in Persian language version.

refsWebsite

Global rank Persian rank

4^th place

5^th place

2^nd place

2^nd place

1medicinenet.com

3,840^th place

1,585^th place

1books.google.com

3^rd place

6^th place

399^th place

104^th place

low place

low place

447^th place

382^nd place

1web.archive.org

1^st place

1^st place

1semanticscholar.org

11^th place

52^nd place

books.google.com

Fischer, Janos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery (به انگلیسی). John Wiley & Sons. p. 505. ISBN 9783527607495.

doi.org

Moyle GJ (August 1996). "Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences". Drugs. 52 (2): 168–85. doi:10.2165/00003495-199652020-00002. PMID 8841736. S2CID 27709969.
Pruvost A, Negredo E, Benech H, Theodoro F, Puig J, Grau E, et al. (May 2005). "Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients". Antimicrobial Agents and Chemotherapy. 49 (5): 1907–14. doi:10.1128/AAC.49.5.1907-1914.2005. PMC 1087635. PMID 15855513.

drugs.com

"Didanosine Side Effects in Detail - Drugs.com". Drugs.com (به انگلیسی). Retrieved 2018-08-08.

fda.gov

"Serious liver disorder associated with the use of Videx/Videx EC (didanosine)". FDA Drug Safety Communication. U.S. Food and Drug Administration. 19 January 2010.

medicinenet.com

"didanosine, Videx, Videx EC: Drug Facts, Side Effects and Dosing". MedicineNet (به انگلیسی). Retrieved 2018-08-08.

nih.gov

pubmed.ncbi.nlm.nih.gov

Moyle GJ (August 1996). "Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences". Drugs. 52 (2): 168–85. doi:10.2165/00003495-199652020-00002. PMID 8841736. S2CID 27709969.
Pruvost A, Negredo E, Benech H, Theodoro F, Puig J, Grau E, et al. (May 2005). "Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients". Antimicrobial Agents and Chemotherapy. 49 (5): 1907–14. doi:10.1128/AAC.49.5.1907-1914.2005. PMC 1087635. PMID 15855513.

aidsinfo.nih.gov

DHHS Panel (May 4, 2006). "Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents". AIDSInfo. U.S. Department of Health and Human Services. Archived from the original on 2006-05-06.

ncbi.nlm.nih.gov

Pruvost A, Negredo E, Benech H, Theodoro F, Puig J, Grau E, et al. (May 2005). "Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients". Antimicrobial Agents and Chemotherapy. 49 (5): 1907–14. doi:10.1128/AAC.49.5.1907-1914.2005. PMC 1087635. PMID 15855513.

semanticscholar.org

api.semanticscholar.org

Moyle GJ (August 1996). "Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences". Drugs. 52 (2): 168–85. doi:10.2165/00003495-199652020-00002. PMID 8841736. S2CID 27709969.

uw.edu

hiv.uw.edu

"Didanosine Videx - Treatment - National HIV Curriculum". www.hiv.uw.edu (به انگلیسی). Retrieved 2018-08-08.

web.archive.org

DHHS Panel (May 4, 2006). "Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents". AIDSInfo. U.S. Department of Health and Human Services. Archived from the original on 2006-05-06.